Phenominer Database Results (40 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Clinical Measurement Notes Record ID Study ID
MWF-Chr 6SHR/Rkb count of superficial glomeruli not directly contacting the kidney surface control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 kidney glomerulus quantity not specified 168 days 19 15.2 null 1.1 4.79 ex vivo light microscopy with digital image analysis 0.0 0 per section 65457 117
MWF-Chr 6SHR/Rkb serum creatinine level control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. blood creatinine amount female 168 days 20 0.48 mg/dl 0.01 0.06 serum creatinine analysis 0.0 0 68176 309
MWF-Chr 6SHR/Rkb negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value control condition (for 0 hours) Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. vasoconstriction trait male 84 days 10 8.1 null 0.1 0.32 wire myography 0.0 0 logarithm of the concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value (CMO:0003677) 109386 3141
MWF-Chr 6SHR/Rkb number of glomeruli per kidney to number of ureteric bud tips per kidney ratio control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. kidney glomerulus quantity not specified -6 days 12 0.59 null 0.03 0.12 immunofluorescence confocal microscopy 0.0 0 immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) number of glomeruli per kidney to number of ureteric bud tips per kidney ratio (CMO:0003849) 109521 3145
MWF-Chr 6SHR/Rkb serum creatinine level control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 blood creatinine amount not specified 168 days 19 0.43 mg/dl 0.02 0.08 serum creatinine analysis 0.0 0 65374 117
MWF-Chr 6SHR/Rkb serum total cholesterol level control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 blood cholesterol amount not specified 168 days 19 74.52 mg/dl 2.32 10.1 serum total cholesterol measurement test 0.0 0 serum triglyceride analysis 65390 117
MWF-Chr 6SHR/Rkb both kidneys wet weight control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 kidney mass not specified 168 days 19 2.11 g 0.07 0.31 post excision weight measurement 0.0 0 65362 117
MWF-Chr 6SHR/Rkb systolic blood pressure control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 arterial blood pressure trait not specified 173 days 19 151.0 mmHg 1.6 6.97 tail cuff piezoplethysmography 0.0 0 12-18 recordings on 3 consecutive days 11689 117
MWF-Chr 6SHR/Rkb kidney glomerulus count control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 kidney glomerulus quantity not specified 28 days 7 N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 34600.0 null 5700.0 15080.78 ex vivo light microscopy with digital image analysis 0.0 0 per kidney 65398 117
MWF-Chr 6SHR/Rkb urine albumin excretion rate control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 urine albumin amount not specified 98 days 19 48.8 mg/d 41.7 181.77 enzyme linked immunosorbent assay 0.0 0 65420 117
MWF-Chr 6SHR/Rkb both kidneys wet weight to body weight ratio control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 kidney mass not specified 168 days 19 5.62 g/kg 0.18 0.78 post excision weight measurement 0.0 0 65365 117
MWF-Chr 6SHR/Rkb systolic blood pressure control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. arterial blood pressure trait female 168 days 20 139.0 mmHg 1.6 7.16 tail cuff plethysmography 0.0 0 68173 309
MWF-Chr 6SHR/Rkb fetal body weight control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. body mass not specified -6 days 12 0.27 g 0.0 0.02 body weighing method 0.0 0 109506 3145
MWF-Chr 6SHR/Rkb body length, crown to rump control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. body length not specified -6 days 12 13.0 mm 0.29 1.0 body length measuring method 0.0 0 body length, crown to rump (CMO:0003847) 109512 3145
MWF-Chr 6SHR/Rkb urine albumin excretion rate control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 urine albumin amount not specified 98 days 19 2.9 mg/d 3.5 15.26 enzyme linked immunosorbent assay 0.0 0 65274 117
MWF-Chr 6SHR/Rkb heart weight to body weight ratio control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. heart mass female 168 days 20 3.08 g/kg 0.1 0.45 post excision weight measurement 0.0 0 12766 309
MWF-Chr 6SHR/Rkb urine albumin level to urine low molecular weight protein ratio control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 urine albumin amount not specified 168 days 19 159.0 % 42.0 183.07 gel electrophoresis 0.0 0 65356 117
MWF-Chr 6SHR/Rkb serum urea nitrogen level control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 blood urea nitrogen amount not specified 168 days 19 21.01 mg/dl 0.7 3.05 serum urea analysis 0.0 0 serum urea analysis 65380 117
MWF-Chr 6SHR/Rkb both kidneys wet weight control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. kidney mass female 168 days 20 1.3 g 0.05 0.22 post excision weight measurement 0.0 0 68170 309
MWF-Chr 6SHR/Rkb number of glomeruli per kidney control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. kidney glomerulus quantity not specified -6 days 12 37.0 null 1.73 6.0 immunofluorescence confocal microscopy 0.0 0 immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) 109515 3145
MWF-Chr 6SHR/Rkb urine albumin excretion rate control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. urine albumin amount female 168 days 0 1.7 mg/d enzyme linked immunosorbent assay 0.0 0 69946 309
MWF-Chr 6SHR/Rkb creatinine clearance to body weight ratio control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. glomerular filtration trait female 168 days 20 0.37 ml/min/100g 0.04 0.18 blood creatinine analysis 0.0 0 68182 309
MWF-Chr 6SHR/Rkb urine albumin excretion rate control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 urine albumin amount not specified 168 days 19 16.6 mg/d 15.2 66.26 enzyme linked immunosorbent assay 0.0 0 65276 117
MWF-Chr 6SHR/Rkb count of superficial glomeruli directly contacting the kidney surface control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 kidney glomerulus quantity not specified 168 days 19 1.6 null 0.4 1.74 ex vivo light microscopy with digital image analysis 0.0 0 per section 65460 117
MWF-Chr 6SHR/Rkb norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL control condition (for 0 hours) Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. vasoconstriction trait male 84 days 10 128.2 % 17.0 53.76 wire myography 0.0 0 norepinephrine-induced blood vessel contractile force expressed as percent of force at baseline (CMO:0003676) 109381 3141
MWF-Chr 6SHR/Rkb fetal body weight control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. body mass not specified -6 days 12 0.27 g 0.01 0.02 body weighing method 0.0 0 109505 3145
MWF-Chr 6SHR/Rkb acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel control condition (for 0 hours) Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. vasodilation trait male 84 days 10 64.0 % 3.8 12.02 wire myography 0.0 0 109371 3141
MWF-Chr 6SHR/Rkb urine albumin level to urine low molecular weight protein ratio control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 urine albumin amount not specified 98 days 19 950.0 % 55.0 239.74 gel electrophoresis 0.0 0 65357 117
MWF-Chr 6SHR/Rkb body weight control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 body mass not specified 168 days 19 375.0 g 8.9 38.79 body weighing method 0.0 0 65359 117
MWF-Chr 6SHR/Rkb body weight control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. body mass female 168 days 20 214.4 g 5.2 23.26 body weighing method 0.0 0 12759 309
MWF-Chr 6SHR/Rkb both kidneys wet weight to body weight ratio control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. kidney mass female 168 days 20 6.06 g/kg 0.16 0.72 post excision weight measurement 0.0 0 12764 309
MWF-Chr 6SHR/Rkb serum triglyceride level control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 blood triglyceride amount not specified 168 days 19 108.85 mg/dl 0.88 3.86 serum triglyceride analysis 0.0 0 serum triglyceride analysis 65385 117
MWF-Chr 6SHR/Rkb urine albumin excretion rate control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 urine albumin amount not specified 56 days 19 0.7 mg/d 0.1 0.44 enzyme linked immunosorbent assay 0.0 0 65272 117
MWF-Chr 6SHR/Rkb systolic blood pressure control condition (for 0 hours) Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. arterial blood pressure trait male 84 days 10 151.0 mmHg 1.6 5.06 tail cuff plethysmography 0.0 0 109287 3141
MWF-Chr 6SHR/Rkb number of ureteric bud tips per kidney control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. ureteric bud morphology trait not specified -6 days 12 64.0 null 3.46 12.0 immunofluorescence confocal microscopy 0.0 0 immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) number of ureteric bud tips per kidney (CMO:0003848) 109518 3145
MWF-Chr 6SHR/Rkb heart wet weight control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. heart mass female 168 days 20 0.66 g 0.03 0.13 post excision weight measurement 0.0 0 12765 309
MWF-Chr 6SHR/Rkb heart wet weight control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 heart mass not specified 168 days 19 0.93 g 0.02 0.09 post excision weight measurement 0.0 0 65368 117
MWF-Chr 6SHR/Rkb heart weight to body weight ratio control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 heart mass not specified 168 days 19 2.47 g/kg 0.05 0.22 post excision weight measurement 0.0 0 65371 117
MWF-Chr 6SHR/Rkb creatinine clearance to body weight ratio control condition Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 glomerular filtration trait not specified 168 days 19 0.59 ml/min/100g 0.04 0.17 blood creatinine analysis 0.0 0 65378 117
MWF-Chr 6SHR/Rkb serum urea nitrogen level control condition Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. blood urea nitrogen amount female 168 days 20 19.27 mg/dl 0.67 3.01 serum urea nitrogen analysis 0.0 0 68179 309